This company listing is no longer active
Salud financiera de hoja de balance de Wockhardt Bio
Salud financiera controles de criterios 4/6
Wockhardt Bio has a total shareholder equity of $281.3M and total debt of $59.2M, which brings its debt-to-equity ratio to 21.1%. Its total assets and total liabilities are $631.9M and $350.6M respectively.
Información clave
21.1%
Ratio deuda-patrimonio
US$59.23m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$38.50m |
| Patrimonio | US$281.28m |
| Total pasivo | US$350.62m |
| Activos totales | US$631.90m |
Actualizaciones recientes sobre salud financiera
Análisis de la situación financiera
Pasivos a corto plazo: WBIO's short term assets ($308.1M) do not cover its short term liabilities ($317.5M).
Pasivo a largo plazo: WBIO's short term assets ($308.1M) exceed its long term liabilities ($33.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: WBIO's net debt to equity ratio (7.4%) is considered satisfactory.
Reducción de la deuda: WBIO's debt to equity ratio has reduced from 103.8% to 21.1% over the past 5 years.
Cobertura de la deuda: WBIO's debt is well covered by operating cash flow (111.6%).
Cobertura de intereses: Insufficient data to determine if WBIO's interest payments on its debt are well covered by EBIT.